New psychoactive drugs.
Many psychologists function in mental health clinics and mental institutions where psychoactive drugs are prescribed and administered or treat patients in therapy for whom psychoactive drugs have been prescribed. Six years ago, psychoactive drugs available to patients and physicians were reviewed for psychologists (Murray, 1978). The variety of psychoactive drugs is greater now, and this review summarizes their impact on the brain and the nervous system and describes their effects on patients' behavior.
Murray
J B
JB
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy; D001921:Brain / Q000187:drug effects; D003692:Delayed-Action Preparations; D003866:Depressive Disorder / Q000188:drug therapy; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D018377:Neurotransmitter Agents / Q000378:metabolism; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy; D009435:Synaptic Transmission / Q000187:drug effects
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D018377:Neurotransmitter Agents; D011619:Psychotropic Drugs; D017981:Receptors, Neurotransmitter